Literature DB >> 18567801

Senescence-dependent MutS alpha dysfunction attenuates mismatch repair.

In-Youb Chang1, Ming Jin, Sang Pil Yoon, Cha-Kyung Youn, Young Yoon, Sung-Pyo Moon, Jin-Won Hyun, Jae Yeoul Jun, Ho Jin You.   

Abstract

DNA damage and mutations in the genome increase with age. To determine the potential mechanisms of senescence-dependent increases in genomic instability, we analyzed DNA mismatch repair (MMR) efficiency in young and senescent human colonic fibroblast and human embryonic lung fibroblast. It was found that MMR activity is significantly reduced in senescent cells. Western blot and immunohistochemistry analysis revealed that hMSH2 and MSH6 protein (MutS alpha complex), which is a known key component in the MMR pathway, is markedly down-regulated in senescent cells. Moreover, the addition of purified MutS alpha to extracts from senescent cells led to the restoration of MMR activity. Semiquantitative reverse transcription-PCR analysis exhibited that MSH2 mRNA level is reduced in senescent cells. In addition, a decrease in E2F transcriptional activity in senescent cells was found to be crucial for MSH2 suppression. E2F1 small interfering RNA expression reduced hMSH2 expression and MMR activity in young human primary fibroblast cells. Importantly, expression of E2F1 in quiescent cells restored the MSH2 expression as well as MMR activity, whereas E2F1-infected senescent cells exhibited no restoration of MSH2 expression and MMR activity. These results indicate that the suppression of E2F1 transcriptional activity in senescent cells lead to stable repression of MSH2, followed by a induction of MutS alpha dysfunction, which results in a reduced cellular MMR capacity in senescent cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18567801     DOI: 10.1158/1541-7786.MCR-07-0380

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  8 in total

1.  Regulation of E2Fs and senescence by PML nuclear bodies.

Authors:  Mathieu Vernier; Véronique Bourdeau; Marie-France Gaumont-Leclerc; Olga Moiseeva; Virginie Bégin; Fred Saad; Anne-Marie Mes-Masson; Gerardo Ferbeyre
Journal:  Genes Dev       Date:  2011-01-01       Impact factor: 11.361

2.  DNA MMR systems, microsatellite instability and antioxidant activity variations in two species of wild bats: Myotis velifer and Desmodus rotundus, as possible factors associated with longevity.

Authors:  Juan C Conde-Pérezprina; Armando Luna-López; Viridiana Y González-Puertos; Tania Zenteno-Savín; Miguel Angel León-Galván; Mina Königsberg
Journal:  Age (Dordr)       Date:  2012-03-28

3.  Effects of lovastatin on breast cancer cells: a proteo-metabonomic study.

Authors:  Jelena Klawitter; Touraj Shokati; Vanessa Moll; Uwe Christians; Jost Klawitter
Journal:  Breast Cancer Res       Date:  2010-03-05       Impact factor: 6.466

4.  Cell-cycle and DNA damage regulation of the DNA mismatch repair protein Msh2 occurs at the transcriptional and post-transcriptional level.

Authors:  Ruth I Tennen; Joanna E Haye; Hashanthi D Wijayatilake; Tim Arlow; Danielle Ponzio; Alison E Gammie
Journal:  DNA Repair (Amst)       Date:  2012-12-20

5.  Mismatch repair single nucleotide polymorphisms and thyroid cancer susceptibility.

Authors:  Luís S Santos; Susana N Silva; Octávia M Gil; Teresa C Ferreira; Edward Limbert; José Rueff
Journal:  Oncol Lett       Date:  2018-02-21       Impact factor: 2.967

Review 6.  Role of mismatch repair in aging.

Authors:  Jie Wen; Yangyang Wang; Minghao Yuan; Zhenting Huang; Qian Zou; Yinshuang Pu; Bin Zhao; Zhiyou Cai
Journal:  Int J Biol Sci       Date:  2021-09-21       Impact factor: 6.580

Review 7.  DNA mismatch repair system: repercussions in cellular homeostasis and relationship with aging.

Authors:  Juan Cristóbal Conde-Pérezprina; Miguel Ángel León-Galván; Mina Konigsberg
Journal:  Oxid Med Cell Longev       Date:  2012-11-08       Impact factor: 6.543

8.  Cell Killing Mechanisms and Impact on Gene Expression by Gemcitabine and 212Pb-Trastuzumab Treatment in a Disseminated i.p. Tumor Model.

Authors:  Kwon Joong Yong; Diane E Milenic; Kwamena E Baidoo; Martin W Brechbiel
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.